Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-001279

Director acquired 95,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hayden Michael R · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-29 Exercise or conversion : show line 1 in the form +50,000 $5.44 $272,000 50,000 D
2021-01-29 Exercise or conversion : show line 2 in the form +30,000 $6.06 $181,800 80,000 D
2021-01-29 Exercise or conversion : show line 3 in the form +15,000 $6.42 $96,300 95,000 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-01-29 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −50,000 0 D
2021-01-29 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −30,000 0 D
2021-01-29 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −15,000 0 D
Loading xslF345X03/wf-form4_161229708841560.xml…